The Berlin Process, set up in 2013, aimed to bring the Western Balkans closer to the EU. So far, the format has mainly been a photo opportunity for politicians. That is about to change at a meeting in Berlin on Thursday.
ROSALIA study met primary endpoints, confirming proposed biosimilar denosumab matches reference product in terms of pharmacokinetics, pharmacodynamics,.
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Sandoz announces further progress on its biosimilar pipeline, with release of positive results for denosumab integrated Phase I/III clinical trial